DiaMedica Therapeutics Inc. (DMAC)
NASDAQ · Healthcare
DiaMedica Therapeutics Inc. Shareholder Equity 2018–2018
DiaMedica Therapeutics Inc. annual shareholder equity history from 2018 to 2018. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- DiaMedica Therapeutics Inc. shareholder equity as of December 31, 2018: 17.0M.
- DiaMedica Therapeutics Inc. shareholder equity for 2018 were 17.0M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| DiaMedica Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2018 | $17 |
DiaMedica Therapeutics Inc. Shareholder Equity — FAQ
DiaMedica Therapeutics Inc. (DMAC) shareholder equity over the last 1 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DMAC's shareholder equity history?
The chart and table above show DiaMedica Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.